These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 28061759)

  • 1. Rheumatic heart disease in Uganda: predictors of morbidity and mortality one year after presentation.
    Okello E; Longenecker CT; Beaton A; Kamya MR; Lwabi P
    BMC Cardiovasc Disord; 2017 Jan; 17(1):20. PubMed ID: 28061759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Latent Rheumatic Heart Disease: Identifying the Children at Highest Risk of Unfavorable Outcome.
    Beaton A; Aliku T; Dewyer A; Jacobs M; Jiang J; Longenecker CT; Lubega S; McCarter R; Mirabel M; Mirembe G; Namuyonga J; Okello E; Scheel A; Tenywa E; Sable C; Lwabi P
    Circulation; 2017 Dec; 136(23):2233-2244. PubMed ID: 28972003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benzathine penicillin adherence for secondary prophylaxis among patients affected with rheumatic heart disease attending Mulago Hospital.
    Musoke C; Mondo CK; Okello E; Zhang W; Kakande B; Nyakoojo W; Freers J
    Cardiovasc J Afr; 2013 May; 24(4):124-9. PubMed ID: 24217043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The personal and clinical impact of screen-detected maternal rheumatic heart disease in Uganda: a prospective follow up study.
    Voleti S; Okello E; Murali M; Sarnacki R; Majwala A; Ssembatya R; Bakka O; Namisanvu H; Njeri A; Matovu A; DeStigter K; Sable C; Beaton A
    BMC Pregnancy Childbirth; 2020 Oct; 20(1):611. PubMed ID: 33036571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intramuscular versus enteral penicillin prophylaxis to prevent progression of rheumatic heart disease: Study protocol for a noninferiority randomized trial (the GOALIE trial).
    Rwebembera J; Ndagire E; Carvalho N; Webel AR; Sable C; Okello E; Sarnacki R; Spaziani AM; Mucunguzi A; Engelman D; Grobler A; Steer A; Beaton A
    Am Heart J; 2024 Sep; 275():74-85. PubMed ID: 38797460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Outcomes in 3343 Children and Adults With Rheumatic Heart Disease From 14 Low- and Middle-Income Countries: Two-Year Follow-Up of the Global Rheumatic Heart Disease Registry (the REMEDY Study).
    Zühlke L; Karthikeyan G; Engel ME; Rangarajan S; Mackie P; Cupido-Katya Mauff B; Islam S; Daniels R; Francis V; Ogendo S; Gitura B; Mondo C; Okello E; Lwabi P; Al-Kebsi MM; Hugo-Hamman C; Sheta SS; Haileamlak A; Daniel W; Goshu DY; Abdissa SG; Desta AG; Shasho BA; Begna DM; ElSayed A; Ibrahim AS; Musuku J; Bode-Thomas F; Yilgwan CC; Amusa GA; Ige O; Okeahialam B; Sutton C; Misra R; Abul Fadl A; Kennedy N; Damasceno A; Sani MU; Ogah OS; Elhassan TO; Mocumbi AO; Adeoye AM; Mntla P; Ojji D; Mucumbitsi J; Teo K; Yusuf S; Mayosi BM
    Circulation; 2016 Nov; 134(19):1456-1466. PubMed ID: 27702773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mortality and Morbidity in Adults With Rheumatic Heart Disease.
    Karthikeyan G; Ntsekhe M; Islam S; Rangarajan S; Avezum A; Benz A; Cabral TTJ; Changsheng M; Chillo P; Gonzalez-Hermosillo JA; Gitura B; Damasceno A; Dans AML; Davletov K; Elghamrawy A; ElSayed A; Fana GT; Gondwe L; Haileamlak A; Kayani AM; Lwabi P; Maklady F; Molefe-Baikai OJ; Musuku J; Ogah OS; Paniagua M; Rusingiza E; Sharma SK; Zuhlke L; Connolly S; Yusuf S;
    JAMA; 2024 Jul; 332(2):133-140. PubMed ID: 38837131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determining the impact of Benzathine penicillin G prophylaxis in children with latent rheumatic heart disease (GOAL trial): Study protocol for a randomized controlled trial.
    Beaton A; Okello E; Engelman D; Grobler A; Scheel A; DeWyer A; Sarnacki R; Omara IO; Rwebembera J; Sable C; Steer A
    Am Heart J; 2019 Sep; 215():95-105. PubMed ID: 31301533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rheumatic heart disease in The Gambia: clinical and valvular aspects at presentation and evolution under penicillin prophylaxis.
    Jaiteh LES; Drammeh L; Anderson ST; Mendy J; Ceesay S; D'Alessandro U; Carapetis J; Mirabel M; Erhart A
    BMC Cardiovasc Disord; 2021 Oct; 21(1):503. PubMed ID: 34663206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secondary prevention of rheumatic heart disease in Ethiopia: a multicenter study.
    Belay W; Dessie A; Ahmed H; Gedlu E; Mariyo A; Shehibo A; Tigabu Z; Aliyu MH; Soslow J
    BMC Cardiovasc Disord; 2022 Feb; 22(1):26. PubMed ID: 35109807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rheumatic Heart Disease Treatment Cascade in Uganda.
    Longenecker CT; Morris SR; Aliku TO; Beaton A; Costa MA; Kamya MR; Kityo C; Lwabi P; Mirembe G; Nampijja D; Rwebembera J; Sable C; Salata RA; Scheel A; Simon DI; Ssinabulya I; Okello E
    Circ Cardiovasc Qual Outcomes; 2017 Nov; 10(11):. PubMed ID: 29133472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-Term Outcomes From Acute Rheumatic Fever and Rheumatic Heart Disease: A Data-Linkage and Survival Analysis Approach.
    He VY; Condon JR; Ralph AP; Zhao Y; Roberts K; de Dassel JL; Currie BJ; Fittock M; Edwards KN; Carapetis JR
    Circulation; 2016 Jul; 134(3):222-32. PubMed ID: 27407071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A qualitative examination of secondary prophylaxis in rheumatic heart disease: factors influencing adherence to secondary prophylaxis in Uganda.
    Huck DM; Nalubwama H; Longenecker CT; Frank SH; Okello E; Webel AR
    Glob Heart; 2015 Mar; 10(1):63-69.e1. PubMed ID: 25754568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical outcomes of children with rheumatic heart disease.
    Zimmerman M; Kitooleko S; Okello E; Ollberding N; Sinha P; Mwambu T; Sable C; Beaton A; Longenecker C; Lwabi P
    Heart; 2022 Apr; 108(8):633-638. PubMed ID: 35110387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes and Care Quality Metrics for Women of Reproductive Age Living With Rheumatic Heart Disease in Uganda.
    Chang AY; Nabbaale J; Okello E; Ssinabulya I; Barry M; Beaton AZ; Webel AR; Longenecker CT
    J Am Heart Assoc; 2020 Apr; 9(8):e015562. PubMed ID: 32295465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electrocardiographic Preexcitation and Risk of Cardiovascular Morbidity and Mortality: Results From the Copenhagen ECG Study.
    Skov MW; Rasmussen PV; Ghouse J; Hansen SM; Graff C; Olesen MS; Pietersen A; Torp-Pedersen C; Haunsø S; Køber L; Svendsen JH; Holst AG; Nielsen JB
    Circ Arrhythm Electrophysiol; 2017 Jun; 10(6):. PubMed ID: 28576781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adherence rates and risk factors for suboptimal adherence to secondary prophylaxis for rheumatic fever.
    Kevat PM; Gunnarsson R; Reeves BM; Ruben AR
    J Paediatr Child Health; 2021 Mar; 57(3):419-424. PubMed ID: 33340191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival of Rheumatic Heart Disease in Indonesian Children.
    Arafuri N; Murni IK; Julia M; Nugroho S; Soehadi N
    Glob Heart; 2022; 17(1):71. PubMed ID: 36382158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adherence to secondary antibiotic prophylaxis for patients with rheumatic heart disease diagnosed through screening in Fiji.
    Engelman D; Mataika RL; Kado JH; Ah Kee M; Donath S; Parks T; Steer AC
    Trop Med Int Health; 2016 Dec; 21(12):1583-1591. PubMed ID: 27730711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adequate adherence to benzathine penicillin secondary prophylaxis following the diagnosis of rheumatic heart disease by echocardiographic screening.
    Culliford-Semmens N; Tilton E; Webb R; Lennon D; Paku B; Malcolm J; French S; Blair N; Wilson N
    N Z Med J; 2017 Jun; 130(1457):50-57. PubMed ID: 28617789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.